Issue of Equity

RNS Number:6106V
Virotec International PLC
27 April 2007

                           VIROTEC INTERNATIONAL PLC
26 April 2007

                              ISSUES OF SECURITIES


Virotec International plc ("Virotec") (AIM:VTI) advises that it has issued the
following securities:

6,655,789  Ordinary shares of 1p each issued at a price of #0.14 per share to 
           the incentive plans for executives as approved by shareholders at 
           the Annual General Meeting on 28 November 2003.

7,000,000  Options exercisable at a price of #0.20 each vesting over 5 years 
           between April 2007 and April 2011 subject to the achievement of
           performance criteria and expiring 3 years after vesting, to the 
           recently appointed CEO, Dr Lee Fergusson, which forms part of his 
           remuneration package for his new position.

3,400,000  Options exercisable at a price of #0.20 each on or before 30 April 
           2012 issued to directors and employees pursuant to the Virotec Option
           Incentive Scheme.

Application will be been made for the 6,655,789 New Ordinary Shares of 1p each
to be admitted to trading on the AIM market of the London Stock Exchange. The
New Ordinary Shares will rank pari passu with existing ordinary shares and it is
expected that admission will become effective at 8.00 a.m. on Tuesday 1 May 
2007.

All of the options noted above were issued to employees pursuant to the Virotec
Option Incentive Scheme (the "Scheme"). Under the terms of the Scheme, options
can generally only be exercised by employees during two periods each year, being
one month immediately following the release of the half year and one month
immediately following the release of the full year financial results.

The following options have lapsed or have been cancelled:

5,000,000  Options exercisable at a price of #0.40 each at various times
           between 1 July 2006 and 30 September 2015 to senior executives.
150,000    Options exercisable at #0.20 each on or before 30 September 2006.
10,000     Options exercisable at #0.20 each on or before 31 March 2007.
110,000    Options exercisable at #0.20 each on or before 30 September 2007.
110,000    Options exercisable at #0.28 each on or before 31 March 2009.


Following successful completion of the placing announced on 28 March 2007 of
17,350,000 ordinary shares, the current issued capital of Virotec following the
issue of the securities referred to above comprises: 

  264,168,231  Ordinary shares of 1p each;  and 
  16,480,000   Options with various expiry dates between 30 September 2007 and 
               30 April 2014 and exercisable at prices between #0.20 and #0.40 
               each.



Angus Craig
Company Secretary



                           VIROTEC INTERNATIONAL PLC
                                   PO BOX 188
                            SANCTUARY COVE QLD 4212
                                   AUSTRALIA
                                www.virotec.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEOKAKBABKDCQB